Ciprofloxacin

Select Content Type
Briefs
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
Cipro_thmbnl
Detail Image
Cipro_mbl
Book Detail
Upload PDF
Ciprofloxacin.pdf (117.03 KB)
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

Ciprofloxacin, a fluoroquinolone antibiotic used for various infections including anthrax, can cause rare but severe reactions such as skin toxicity, agranulocytosis, and hypersensitivity. Tendon rupture risk increases with steroid use. The drug inhibits CYP3A4 and CYP1A2 enzymes, leading to potential drug interactions. Overdose is usually managed with supportive care, though renal failure and seizures have been reported.
Read the full chapter on Ciprofloxacin here: https://www.sciencedirect.com/topics/chemistry/ciprofloxacin

Published Date